✦ LIBER ✦

Re: A Randomised, Double-Blind Phase III Study of Pazopanib in Patients with Advanced and/or Metastatic Renal Cell Carcinoma: Final Overall Survival Results and Safety Update

✍ Scribed by Laguna, M. Pilar

Book ID: 122867599
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 190
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.08.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, double-blind phase III stu

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

✍ Sternberg, Cora N.; Hawkins, Robert E.; Wagstaff, John; Salman, Pamela; Mardiak, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Re: Pazopanib in Locally Advanced or Met

Re: Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

✍ Taneja, Samir S. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

7119 Genitourinary malignancies – Renal

7119 Genitourinary malignancies – Renal cancer Quality of life (QOL) in treatment-naïve and cytokine-pretreated patients with advanced renal cell carcinoma (RCC) treated with pazopanib: results from a phase III double-blind, placebo-controlled trial

✍ Hawkins, R.; Hodge, R.; Chen, M.; Neary, M.; Pickard, A.S.; Sternberg, C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Overall survival and good tolerability o

Overall survival and good tolerability of long-term use of sorafenib after cytokine treatment: final results of a phase II trial of sorafenib in Japanese patients with metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Masaru Murai; Koichi Fukino; Hideyuki Akaza 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Biomarker Analyses and Final Overall Sur

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS)

✍ Fukuoka, M.; Wu, Y.-L.; Thongprasert, S.; Sunpaweravong, P.; Leong, S.-S.; Sriur 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 241 KB

Rationale and Design of MARQUEE: A Phase

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB